Abstract
Schistosomiasis is a tropical disease currently found in approximately 70 countries, mainly in Africa, the Eastern Mediterranean, and South America. An estimated 200 million people are infected. Schistosomiasis-associated kidney disease is not often described in the literature, and most studies show an association between the disease and glomerular alterations, especially in those patients with more severe clinical presentation. In this chapter, we review the general aspects of the disease and describe the characteristics of renal involvement in schistosomiasis mansoni. The disease is associated with high morbidity and mortality, and chronic complications are usually seen in individuals with high parasite burden, which usually occurs in those living in endemic areas. The clinical presentation of schistosomiasis results from the host’s immune response to Schistosoma eggs and the granulomatous reaction elicited by the antigens that they secrete. The immunological nature of the glomerular lesion is well established, and depends on the release of antigenic molecules produced by the parasite, triggering the formation of immune complexes that are deposited in the glomeruli. Although antigens from the adult worm are the most often related to schistosomal glomerulopathy, soluble egg antigens also contribute to the pathogenesis of glomerulopathy, as demonstrated in experimental studies. Glomerular injury is also related to the parasitosis intensity and the type and duration of the process. Membranoproliferative glomerulonephritis and focal and segmental glomerulosclerosis (FSGS) represent the patterns of glomerular injury most consistently associated with the hepatosplenic form of schistosomiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AAF M. Esquistossomose. In: Bennett JC, Plum F, editors. Cecil: Tratado de Medicina Interna. 20th ed. Rio de Janeiro: Guanabara-Koogan; 1997. p. 2127–32.
Ross AGP, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–20.
Chitsulo L, Loverde P, Engels D. Disease watch: schistosomiasis. TDR Nat Rev Microbiol. 2004;2:12–3.
Maguire JH. Trematodes (Schistosomes and Other Flukes). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s: principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 3595–605.
Molyneu DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med. 2005;2:1064–70.
Vanderwerf MJ, De Valasl SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86:125–39.
Steinmann P, Keiser J, Bos R, et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411–25.
Passos ADC, Amaral RS. Esquistossomose mansônica: aspectos epidemiológicos e de controle. Rev Soc Bras Med Trop. 1998;31:61–74.
Katz N, Peixoto SV. Análise crítica da estimativa do número de portadores de esquistossomose mansoni no Brasil. Rev Soc Bras Med Trop. 2000;33:303–8.
Resendes APC, Souza SR, Barbosa CS. Hospitalization and mortality from mansoni schistosomiasis in the State of Pernambuco, Brazil,1992/2000. Cad Saúde Pública. 2005;21:1392–401.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica. 7th ed. Brasília, DF; 2010.
BRASIL. Ministério da Saúde. Sistema de informação de agravos de notificação/ Sistema de informação da esquistossomose. Casos confirmados de Esquistossomose: Brasil, Grandes Regiões e Unidades Federadas. 1995a 2011. Brasília; 2012. Available at:http://portal.saude.gov.br/portal/arquivos/pdf/serie_historica_esquistossomose_07_08_2012.pdf. Accessed 03 abr 2013.
Ministério da Saúde. DATASUS. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinan/pce/ cnv/pcebr.def. Accessed 25 Mar 2018.
Blanchard TJ. Schistosomiasis. Travel Med Infect Dis. 2004;2:5–11.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Doenças infecciosas e parasitárias: guia de bolso. 5. ed. ampl. Brasília; 2005a. Available at: www.saude.gov.br/svs. Accessed 8 Mar 2012.
Martinelli R, Silveira MA, Rocha H. Glomerulonefrites associadas às doenças parasitárias. In: Barros RT, editor. Glomerulopatias: patogenia, clínica e tratamento. São Paulo: Sarvier; 2006. p. 352–71.
Domingues ALC, Novais S. Esquistossomose mansônica. In: Filgueira NA, editor. Condutas em clínica médica. Rio de Janeiro: Medsi; 2004. p. 659–69.
Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis. 2007;195:288–95.
Cheever AW, Hoffmann KF, Wynn TA. Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today. 2000;21:465–6.
Corachan M. Schistosomiasis and international travel. Clin Infect Dis. 2002;35:446–50.
Mountford AP. Immunological aspects of schistosomiasis. Parasite Immunol. 2005;27:243–6.
Bina JC. Influência da terapêutica específica na evolução da esquistossomose mansoni. Rev Patol Trop. 1981;10:221–67.
Stephenson L. The impact of schistosomiasis on human nutrition. Parasitology. 1993;107:107–23.
Lamyman MJ, Noble DJ, Narang S, Dehalvi N. Small bowel obstruction secondary to intestinal schistosomiasis. Trans R Soc Trop Med Hyg. 2006;100:885–7.
Domingues ALC, Domingues LAW. Forma intestinal, hepatointestinal e hepatoesplênica. In: Malta J, editor. Esquistossomose mansônica, vol. 5. Recife: Ed UFPE; 1994. p. 91–105.
Lambertucci JR, Serufo JC, Gerspacher-Lara R, et al. Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop. 2000;77:101–9.
Andrade ZA, Van Marck EAE. Schistosomal glomerular disease. Mem Inst Oswaldo Cruz. 1984;79:499–506.
Prata A. Esquistossomose mansoni. In: Veronesi R, Foccacia R, editors. Tratado de Infectologia. São Paulo: Atheneu; 1997. p. 1354–72.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa de Controle da Esquistossomose. Brasília; 2006.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Vigilância da Esquistossomose Mansoni: diretrizes técnicas/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. 4th ed. Brasília: Ministério da Saúde; 2014. 144p: il.
Barsoum RS. Schistosomal glomerulopathies. Kidney Int. 1993;44:1–12.
Van Velthuysen MLF. Glomerulopathy associated with parasitic infections. ParasitToday. 1996;12:102–7.
Rodrigues VL, Otoni A, Voieta I, et al. Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. Rev Soc Bras Med Trop. 2010;43:638–42.
Queiroz FP, Brito E, Martinelli R. Influence of regional factors in the distribution of the histologic patterns of glomerulopathies in the nephrotic syndrome. Nephron. 1975;14:466–70.
Dos Santos WLC, Sweet GMM, Azevêdo LG, et al. Current distribution pattern of biopsy-proven glomerular disease in Salvador, Brazil, 40 years after an initial assessment. Braz J Nephrol. 2017;39(4):376–83.
Melo ME, Silveira MA, Martinelli R. Alterações renais nas doenças parasitárias: esquistossomose, leptospirose e malária. In: Barros E, editor. Nefrologia: rotinas, diagnóstico e tratamento. Porto Alegre: Artmed; 2006. p. 309–16.
Deelder AM, Kornelis D, Marck V, et al. Schistosoma mansoni: characterization of two circulating polysaccharide antigens and the immunological response to these antigens in the mouse, hamster, and human infection. Exp. Parasitology. 1980;50:16–32.
Van Marck EA, Deelder AM, Gigase PL. Effect of partial portal vein ligation on immune glomerular deposits in Schistosoma mansoni infected mice. Br J Exp Pathol. 1977;58:412–7.
De Water R, Van Marck EA, Fransen JA, et al. Schistosoma mansoni: ultrastructural localization of the circulating anodic antigen and the circulating cathodic antigen in the mouse kidney glomerulus. Am J Trop Med Hyg. 1988;38:118–24.
Barsoum RS. Schistosomal glomerulopathy: selection factors. Nephrol Dial Transplant. 1987;2:488–97.
De Brito T, Carneiro CR, Nakhle MC, et al. Localization by immunoelectron microscopy of Schistosoma mansoni antigens in the glomerulus of the hamster (Mesocricetusauratus). Kidney Exp Nephrol. 1998;6:368–76.
Digeon M, Droz D, Noel LH, et al. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis. Clin Exp Immunol. 1979;35:329–37.
Sobh M, Moustafa F, Ramzy R, et al. Schistosoma mansoni nephropathy in Syrian golden hamsters: effect of dose and duration of infection. Nephron. 1991;59:121–30.
Barsoum R. The changing face of schistosomal glomerulopathy. Kidney Int. 2004;66:2472–84.
Brito T. Schistosoma mansoni associated glomerulopathy. Rev Inst Med Trop. 1999;41:269–72.
Nussenzveig I, De Brito T, Carneiro CR, et al. Human Schistosoma mansoni-associated glomerulopathy in Brazil. Nephrol Dial Transplant. 2002;17:4–7.
Abensur H, Nussenzveig I, Saldanha LB, et al. Nephrotic syndrome associated with hepatointestinal schistosomiasis. Rev Inst Med Trop Sao Paulo. 1992;34:273–6.
Dos Santos WLC, Sweet GMM, Bahiense-Oliveira M, et al. Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil. Mem Inst Oswaldo Cruz. 2011;106:901–4.
Andrade ZA, Rocha H. Schistosomal glomerulopathy. Kidney Int. 1979;16:23–9.
Martinelli R, Rocha H. Revisão/Atualização em Nefrologia Clínica: Envolvimento glomerular na esquistossomose mansônica. J Bras Nefrol. 1996;18:279–82.
Silva Júnior GB, Duarte DB, Barros EJG, et al. Schistosomiasis-associated kidney disease: a review. Asian Pac J Trop Dis. 2013;3:79–84.
Martinelli R, Brito E, Rocha H. Value of beta 1C/1A globulin serum levels as an early index of glomerular involvement in Schistosoma mansoni infection. Am J Trop Med Hyg. 1980;29:882–995.
Duarte DB, Vanderlei LA, Bispo RKV, et al. Renal function in Hepatosplenic schistosomiasis – an assessment of renal tubular disorders. PLoS One. 2014;9:1–15.
Sobh M, Moustafa F, El-Arbagy, et al. Nephropathy in asymptomatic patients with active Schistosoma mansoni infection. Inter Urol Nephr. 1990;22:37–43.
Hanemann ALP, Libório AB, Daher EF, et al. Monocyte chemotactic Protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation. PLoS One. 2013;8:1–5.
Martinelli R, Noblat ACB, Brito E, et al. Schistosoma mansoni-induced mesangiocapillary glomerulonephrites: influence of therapy. Kidney Int. 1989;35:1227–33.
Lima Verde EM, Lima Verde FAA, Silva Júnior GB, et al. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol. 2007;20:432–8.
Oliveira RA, Silva Júnior GB, Souza CJ, et al. Evaluation of renal function in leprosy: a study of 59 consecutive patients. Nephrol Dial Transplant. 2008;23:256–62.
Oliveira RA, Lima CG, Mota RMS, et al. Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial. BMC Nephrol. 2012;13:44–9.
Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50–64.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.
Duarte DB, Vanderlei LA, Bispo RKV, et al. Acute kidney injury in schistosomiasis: a retrospective cohort of 60 patients in Brazil. J Parasitol. 2015;101:244–7.
Jiang Y, Beller DI, Frendl G, et al. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992;148:2423–8.
Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11:152–76.
Gryseels B, Polman K, Clerinx J, et al. Human schistosomiasis. Lancet. 2006;368:1106–18.
Martinelli R, Pereira JLC, Brito E, et al. Clinical course of focal segmental glomerulosclerosis associated with hepatosplenic Schistosomiasis mansoni. Nephron. 1995;69:131–4.
Acknowledgments
To Fabio Rocha, for his help in developing the figures used in the chapter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Duarte, D.B., De Francesco Daher, E., Pinheiro, M.E., Oliveira, M.J.C. (2020). Schistosomiasis Mansoni-Associated Kidney Disease. In: Bezerra da Silva Junior, G., De Francesco Daher, E., Barros, E. (eds) Tropical Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-44500-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-44500-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44499-0
Online ISBN: 978-3-030-44500-3
eBook Packages: MedicineMedicine (R0)